Neoadjuvant Therapy Regimens for Hilar Cholangiocarcinoma Before Liver Transplant
Samuel J. Keltner(University of Cincinnati), Julie K. Heimbach(Mayo Clinic in Arizona), Randa Tao(University of Utah), Christopher L. Hallemeier(Mayo Clinic in Arizona), Shimul A. Shah(University of Cincinnati Medical Center), Jordan Kharofa(Medical College of Wisconsin), K. Wang(University of North Carolina at Chapel Hill)
International Journal of Radiation Oncology*Biology*Physics
October 25, 2021
Cited by 2
Related Papers
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.1k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
|Gastroenterology|2012|589
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era
|Gastroenterology|2021|583